These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
508 related articles for article (PubMed ID: 34225545)
1. Antimicrobial resistance in low- and middle-income countries: current status and future directions. Sulis G; Sayood S; Gandra S Expert Rev Anti Infect Ther; 2022 Feb; 20(2):147-160. PubMed ID: 34225545 [TBL] [Abstract][Full Text] [Related]
2. Coverage of policies to improve antimicrobial stewardship in human medicine in low and middle income countries: results from the Global Survey of Experts on Antimicrobial Resistance. Zay Ya K; Lambiris MJ; Levine GA; Tediosi F; Fink G BMC Public Health; 2024 Aug; 24(1):2297. PubMed ID: 39180027 [TBL] [Abstract][Full Text] [Related]
3. Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries. Gandra S; Alvarez-Uria G; Turner P; Joshi J; Limmathurotsakul D; van Doorn HR Clin Microbiol Rev; 2020 Sep; 33(3):. PubMed ID: 32522747 [TBL] [Abstract][Full Text] [Related]
4. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey. Tomczyk S; Taylor A; Brown A; de Kraker MEA; El-Saed A; Alshamrani M; Hendriksen RS; Jacob M; Löfmark S; Perovic O; Shetty N; Sievert D; Smith R; Stelling J; Thakur S; Vietor AC; Eckmanns T; J Antimicrob Chemother; 2021 Oct; 76(11):3045-3058. PubMed ID: 34473285 [TBL] [Abstract][Full Text] [Related]
5. Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries. Lim C; Ashley EA; Hamers RL; Turner P; Kesteman T; Akech S; Corso A; Mayxay M; Okeke IN; Limmathurotsakul D; van Doorn HR Clin Microbiol Infect; 2021 Oct; 27(10):1391-1399. PubMed ID: 34111583 [TBL] [Abstract][Full Text] [Related]
6. What are the most effective community-based antimicrobial stewardship interventions in low- and middle-income countries? A narrative review. Lam TT; Dang DA; Tran HH; Do DV; Le H; Negin J; Jan S; Marks GB; Nguyen TA; Fox GJ; Beardsley J J Antimicrob Chemother; 2021 Apr; 76(5):1117-1129. PubMed ID: 33491090 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial resistance landscape and COVID-19 impact in Egypt, Iraq, Jordan, and Lebanon: A survey-based study and expert opinion. Bizri AR; El-Fattah AA; Bazaraa HM; Al Ramahi JW; Matar M; Ali RAN; El Masry R; Moussa J; Abbas AJA; Aziz MA PLoS One; 2023; 18(7):e0288550. PubMed ID: 37498951 [TBL] [Abstract][Full Text] [Related]
8. Exploring the factors that contribute to the successful implementation of antimicrobial resistance interventions: a comparison of high-income and low-middle-income countries. Graells T; Lambraki IA; Cousins M; Léger A; Henriksson PJG; Troell M; Carson CA; Parmley EJ; Majowicz SE; Wernli D; Jørgensen PS Front Public Health; 2023; 11():1230848. PubMed ID: 37900049 [TBL] [Abstract][Full Text] [Related]
9. Setting up laboratory-based antimicrobial resistance surveillance in low- and middle-income countries: lessons learned from Georgia. Malania L; Wagenaar I; Karatuna O; Tambic Andrasevic A; Tsereteli D; Baidauri M; Imnadze P; Nahrgang S; Ruesen C Clin Microbiol Infect; 2021 Oct; 27(10):1409-1413. PubMed ID: 34044149 [TBL] [Abstract][Full Text] [Related]
10. 'LMICs as reservoirs of AMR': a comparative analysis of policy discourse on antimicrobial resistance with reference to Pakistan. Khan MS; Durrance-Bagale A; Legido-Quigley H; Mateus A; Hasan R; Spencer J; Hanefeld J Health Policy Plan; 2019 Apr; 34(3):178-187. PubMed ID: 30977804 [TBL] [Abstract][Full Text] [Related]
11. Methodological Approach to Identify and Expand the Volume of Antimicrobial Resistance (AMR) Data in the Human Health Sector in Low- and Middle-Income Countries in Asia: Implications for Local and Regional AMR Surveillance Systems Strengthening. Joh HS; Yeats C; Shaw A; Poudyal N; Gallagher P; Kim JH; Shaikh A; Seo HJ; Chi KK; Prifti K; Cho A; Sujan MJ; Eraly E; Pham KD; Shrestha S; Aboushady AT; Pak G; Jang G; Park EL; Seo HW; Abudahab K; Taylor BEW; Clark A; Dolabella B; Yoon H; Han J; Kwon SY; Marks F; Stelling J; Aanensen DM; MacWright WR; Holm M Clin Infect Dis; 2023 Dec; 77(Suppl 7):S507-S518. PubMed ID: 38118007 [TBL] [Abstract][Full Text] [Related]
12. Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility. Sharma A; Singh A; Dar MA; Kaur RJ; Charan J; Iskandar K; Haque M; Murti K; Ravichandiran V; Dhingra S J Infect Public Health; 2022 Feb; 15(2):172-181. PubMed ID: 34972026 [TBL] [Abstract][Full Text] [Related]
13. Post COVID Antimicrobial Resistance Threat in Lower- and Middle-Income Countries: Bangladesh. Mahadi AR Front Public Health; 2021; 9():770593. PubMed ID: 34976929 [No Abstract] [Full Text] [Related]
14. Building resilient and responsive research collaborations to tackle antimicrobial resistance-Lessons learnt from India, South Africa, and UK. Veepanattu P; Singh S; Mendelson M; Nampoothiri V; Edathadatil F; Surendran S; Bonaconsa C; Mbamalu O; Ahuja S; Birgand G; Tarrant C; Sevdalis N; Ahmad R; Castro-Sanchez E; Holmes A; Charani E Int J Infect Dis; 2020 Nov; 100():278-282. PubMed ID: 32860949 [TBL] [Abstract][Full Text] [Related]
15. Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis. Lewnard JA; Charani E; Gleason A; Hsu LY; Khan WA; Karkey A; Chandler CIR; Mashe T; Khan EA; Bulabula ANH; Donado-Godoy P; Laxminarayan R Lancet; 2024 Jun; 403(10442):2439-2454. PubMed ID: 38797180 [TBL] [Abstract][Full Text] [Related]
16. Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications. Saleem Z; Godman B; Azhar F; Kalungia AC; Fadare J; Opanga S; Markovic-Pekovic V; Hoxha I; Saeed A; Al-Gethamy M; Haseeb A; Salman M; Khan AA; Nadeem MU; Rehman IU; Qamar MU; Amir A; Ikram A; Hassali MA Expert Rev Anti Infect Ther; 2022 Jan; 20(1):71-93. PubMed ID: 34038294 [TBL] [Abstract][Full Text] [Related]
17. A road-map for addressing antimicrobial resistance in low- and middle-income countries: lessons learnt from the public private participation and co-designed antimicrobial stewardship programme in the State of Kerala, India. Singh S; Charani E; Devi S; Sharma A; Edathadathil F; Kumar A; Warrier A; Shareek PS; Jaykrishnan AV; Ellangovan K Antimicrob Resist Infect Control; 2021 Feb; 10(1):32. PubMed ID: 33573697 [TBL] [Abstract][Full Text] [Related]
18. How can lessons from the COVID-19 pandemic enhance antimicrobial resistance surveillance and stewardship? Walia K; Mendelson M; Kang G; Venkatasubramanian R; Sinha R; Vijay S; Veeraraghavan B; Basnyat B; Rodrigues C; Bansal N; Ray P; Mathur P; Gopalakrishnan R; Ohri VC Lancet Infect Dis; 2023 Aug; 23(8):e301-e309. PubMed ID: 37290476 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial Resistance Threats in the emerging COVID-19 pandemic: Where do we stand? Ghosh S; Bornman C; Zafer MM J Infect Public Health; 2021 May; 14(5):555-560. PubMed ID: 33848884 [TBL] [Abstract][Full Text] [Related]